Canadian Body Addresses Shortages Risk

Warns Skyrocketing Transportation Costs Could Cause Supply Chain Disruption

The CGPA and Biosimilars Canada have acknowledged the risk of local shortages amid the coronavirus crisis, after Health Canada advised Canadians that buying more medicine than usual could lead to local supply disruptions.

Canada
The CGPA and Biosimilars Canada are collaborating with international agencies to mitigate potential drug shortages • Source: Shutterstock

More from Generics

More from Products